spacer
home > ebr > winter 2002 > the splice of life
PUBLICATIONS
European Biopharmaceutical Review

The Splice of Life

Converting knowledge derived from genomics into therapeutics was never going to be straightforward. Simply knowing the number and sequence of genes in the human genome is not enough. Instead, researchers need to understand the functions of the huge diversity of proteins produced by this genetic code, as proteins are responsible for most cellular activities and form the majority of drug targets.

This is one reason for the huge growth in proteomics research, as researchers try to elucidate cellular events at the level of proteins. However, proteomics requires studies on a far greater scale than genomics. This is due to the vast number of different proteins produced by post-translational modifications, polyadenylation (1) and, perhaps most importantly, the way in which RNA is processed.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Fabien Schweighoffer PhD, Executive Vice-President of Therapeutic Programs at ExonHit Therapeutics Dr Fabien Schweighoffer is one of the founders of ExonHit Therapeutics. Previous to this he was employed as a Research Scientist in the Molecular Biology department of Rhфne-Poulenc Rorer (now Aventis) for 10 years.
Fabien holds a PhD in Biochemistry from the University of Paris, has published many papers and received several awards..

spacer
Dr Fabien Schweighoffer
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AstroNova introduces its range of grass paper labels derived from grass for high quality organic products

Dietzenbach, 29 April 2019, AstroNova GmbH, European headquarters of AstroNova Inc. (RI, USA), responsible for Sales and Customer Service in Europe, the Middle East and Africa (EMEA), is extending its Product Identification range with new approved labelling for direct foodstuff contact.
More info >>

White Papers

Systems Engineering for Complex Portable Medical Device Development

Phillips-Medisize

As the demand for complex, portable medical devices continues to grow, reducing risk and increasing efficiency during the development of these products should be paramount. Taking a systems-engineering (SE) approach to development provides a holistic, organized, and deliberate method for identifying as well as reducing both patient and business risks early in the process. Furthermore, it facilitates efficient progression throughout the entire product development life cycle.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement